Study of Amyloidosis Frequency in Patients Having Trauma Surgery Using a Red Flags Tool

What this Trial Is About

Researchers are studying how often amyloidosis occurs in patients who are undergoing trauma surgery. This observational study is designed to identify the presence of amyloidosis using a red flags tool among adults and elderly patients who are on a waiting list for scheduled trauma surgery and meet specific risk criteria. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf and aims to provide important insights into the frequency of this condition in the trauma surgery population. The study involves patients who are scheduled for trauma surgery and who meet at least one red flag criterion, such as age over 65, possible family history of amyloidosis, or certain cardiac, nerve, kidney, or liver conditions without clear causes. Participants will be observed and evaluated for amyloidosis through clinical assessments and necessary tests during their pre-surgery evaluations. No experimental drugs or interventions are administered, as this is an observational study. Participants will be involved in evaluations necessary to detect amyloidosis, including clinical assessments and review of medical history related to heart, nerve, kidney, and liver health. The main outcome measured is the presence of amyloidosis within one month. Participants need to be able to cooperate with these evaluations and provide informed consent. The study does not involve any treatment and focuses on data collection and monitoring during the pre-surgery period and shortly after.

Prevalence of Amyloidosis in Trauma Patients